{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T18:49:22Z","timestamp":1781549362634,"version":"3.54.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T00:00:00Z","timestamp":1751155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T00:00:00Z","timestamp":1751155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s40262-025-01543-y","type":"journal-article","created":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T02:04:52Z","timestamp":1751162692000},"page":"1331-1340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacokinetics of Sufentanil After Epidural Administration During the Course of Extensive Abdominal Surgery"],"prefix":"10.1007","volume":"64","clinical-trial-number":[{"clinical-trial-number":"nct06069219","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Agnieszka","family":"Bienert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka Borsuk-De","family":"Moor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Oku\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta","family":"Siluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Waszczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Kusza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Bartkowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Szrama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kluzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Koszel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2878-3161","authenticated-orcid":false,"given":"Pawe\u0142","family":"Wiczling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,29]]},"reference":[{"key":"1543_CR1","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1460-9592.2010.03411.x","volume":"21","author":"S Lundeberg","year":"2011","unstructured":"Lundeberg S, Roelofse JA. Aspects of pharmacokinetics and pharmacodynamics of sufentanil in pediatric practice. Paediatr Anaesth. 2011;21:274\u20139.","journal-title":"Paediatr Anaesth"},{"key":"1543_CR2","first-page":"35","volume":"44","author":"D Maciejewski","year":"2012","unstructured":"Maciejewski D. Sufentanil in anaesthesiology and intensive therapy. Anaesthesiol Intensive Ther. 2012;44:35\u201341.","journal-title":"Anaesthesiol. Intensive Ther."},{"key":"1543_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1136\/bjsports-2017-098046","volume":"53","author":"S Mart\u00edn-Rodr\u00edguez","year":"2019","unstructured":"Mart\u00edn-Rodr\u00edguez S, B\u00f8 K. Is abdominal hypopressive technique effective in the prevention and treatment of pelvic floor dysfunction? Marketing or evidence from high-quality clinical trials? Br J Sports Med. 2019;53:135\u20136.","journal-title":"Br J Sports Med"},{"key":"1543_CR4","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1007\/s00134-003-1920-y","volume":"29","author":"F Ethuin","year":"2003","unstructured":"Ethuin F, Boudaoud S, Leblanc I, Troje C, Marie O, Levron J-C, Le Moing J-P, Assoune P, Eurin B, Jacob L. Pharmacokinetics of long-term sufentanil infusion for sedation in ICU patients. Intensive Care Med. 2003;29:1916\u201320. https:\/\/doi.org\/10.1007\/s00134-003-1920-y.","journal-title":"Intensive Care Med"},{"key":"1543_CR5","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1159\/000515787","volume":"106","author":"P Pokorn\u00e1","year":"2021","unstructured":"Pokorn\u00e1 P, \u0160\u00edma M, Koch B, Tibboel D, Slana\u0159 O. Sufentanil disposition and pharmacokinetic model-based dosage regimen for sufentanil in ventilated full-term neonates. Pharmacology. 2021;106:384\u20139. https:\/\/doi.org\/10.1159\/000515787.","journal-title":"Pharmacology"},{"key":"1543_CR6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/0267659118824011","volume":"34","author":"P Pokorn\u00e1","year":"2019","unstructured":"Pokorn\u00e1 P, \u0160\u00edma M, Vobruba V, Ba\u0161kov\u00e1 M, Posch L, Slana\u0159 O. Sufentanil pharmacokinetics in a full-term neonate treated with extracorporeal membrane oxygenation: a case report. Perfusion. 2019;34:433\u20136. https:\/\/doi.org\/10.1177\/0267659118824011.","journal-title":"Perfusion"},{"key":"1543_CR7","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1002\/psp4.13205","volume":"13","author":"V Khaowroongrueng","year":"2024","unstructured":"Khaowroongrueng V, Son KH, Lee S-M, Lee J, Park C-G, Lee SI, Shin D, Shin K-H. Population pharmacokinetic modeling of sufentanil in adult Korean patients undergoing cardiopulmonary bypass surgery. CPT Pharmacometr Syst Pharmacol. 2024;13:1682\u201392. https:\/\/doi.org\/10.1002\/psp4.13205.","journal-title":"CPT Pharmacometr Syst Pharmacol"},{"key":"1543_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s13054-019-2508-4","volume":"23","author":"J Hahn","year":"2019","unstructured":"Hahn J, Yang S, Min KL, Kim D, Jin BH, Park C, Park MS, Wi J, Chang MJ. Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy. Crit Care. 2019;23:248. https:\/\/doi.org\/10.1186\/s13054-019-2508-4.","journal-title":"Crit Care"},{"key":"1543_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1213\/00000539-198703000-00001","volume":"66","author":"PJ Davis","year":"1987","unstructured":"Davis PJ, Cook DR, Stiller RL, Davin-Robinson KA. Pharmacodynamics and pharmacokinetics of high-dose sufentanil in infants and children undergoing cardiac surgery. Anesth Analg. 1987;66:203\u20138.","journal-title":"Anesth Analg"},{"key":"1543_CR10","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1097\/00000542-199512000-00010","volume":"83","author":"E Gepts","year":"1995","unstructured":"Gepts E, Shafer SL, Camu F, Stanski DR, Woestenborghs R, Van Peer A, Heykants JJ. Linearity of pharmacokinetics and model estimation of sufentanil. Anesthesiology. 1995;83:1194\u2013204. https:\/\/doi.org\/10.1097\/00000542-199512000-00010.","journal-title":"Anesthesiology"},{"key":"1543_CR11","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/pan.12440","volume":"24","author":"B Woloszczuk-Gebicka","year":"2014","unstructured":"Woloszczuk-Gebicka B, Grabowski T, Borucka B, Karas-Trzeciak M. Pharmacokinetics of sufentanil administered with 0.2% ropivacaine as a continuous epidural infusion for postoperative pain relief in infants. Paediatr Anaesth. 2014;24:962\u20137.","journal-title":"Paediatr Anaesth"},{"key":"1543_CR12","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1002\/jcph.912","volume":"57","author":"A Borsuk","year":"2017","unstructured":"Borsuk A, Wo\u0142oszczuk-G\u0119bicka B, Bartkowska-\u015aniatkowska A, Rosada-Kurasi\u0144ska J, Bienert A, Wiczling P. Flip-flop phenomenon in epidural sufentanil pharmacokinetics: a population study in children and infants. J Clin Pharmacol. 2017;57:1194\u2013206. https:\/\/doi.org\/10.1002\/jcph.912.","journal-title":"J Clin Pharmacol"},{"key":"1543_CR13","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2165\/00003088-199223030-00005","volume":"23","author":"RH Taverne","year":"1992","unstructured":"Taverne RH, Ionescu TI, Nuyten ST. Comparative absorption and distribution pharmacokinetics of intravenous and epidural sufentanil for major abdominal surgery. Clin Pharmacokinet. 1992;23:231\u20137.","journal-title":"Clin Pharmacokinet"},{"key":"1543_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1213\/00000539-200108000-00046","volume":"93","author":"C Menigaux","year":"2001","unstructured":"Menigaux C, Guignard B, Fletcher D, Sessler DI, Levron JC, Chauvin M. More epidural than intravenous sufentanil is required to provide comparable postoperative pain relief. Anesth Analg. 2001;93:472\u20136 (4th contents page).","journal-title":"Anesth Analg"},{"key":"1543_CR15","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1213\/00000539-199306000-00011","volume":"76","author":"E Geller","year":"1993","unstructured":"Geller E, Chrubasik J, Graf R, Chrubasik S, Schulte-M\u00f6nting J. A randomized double-blind comparison of epidural sufentanil versus intravenous sufentanil or epidural fentanyl analgesia after major abdominal surgery. Anesth Analg. 1993;76:1243\u201350.","journal-title":"Anesth Analg"},{"key":"1543_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/jcph.577","volume":"56","author":"A Bartkowska-\u015aniatkowska","year":"2016","unstructured":"Bartkowska-\u015aniatkowska A, Bienert A, Wiczling P, Rosada-Kurasi\u0144ska J, Zieli\u0144ska M, Warzybok J, Borsuk A, Tibboel D, Kaliszan R, Grze\u015bkowiak E. Pharmacokinetics of sufentanil during long-term infusion in critically ill pediatric patients. J Clin Pharmacol. 2016;56:109\u201315. https:\/\/doi.org\/10.1002\/jcph.577.","journal-title":"J Clin Pharmacol"},{"key":"1543_CR17","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1002\/sim.3722","volume":"28","author":"B Neuenschwander","year":"2009","unstructured":"Neuenschwander B, Branson M, Spiegelhalter DJ. A note on the power prior. Stat Med. 2009;28:3562\u20136. https:\/\/doi.org\/10.1002\/sim.3722.","journal-title":"Stat Med"},{"key":"1543_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2165\/00003088-198713030-00004","volume":"13","author":"AGL Burm","year":"1987","unstructured":"Burm AGL, Vermeulen NPE, van Kleef JW, de Boer AG, Spierdijk J, Breimer DD. Pharmacokinetics of lignocaine and bupivacaine in surgical patients following epidural administration. Clin Pharmacokinet. 1987;13:191\u2013203.","journal-title":"Clin Pharmacokinet"},{"key":"1543_CR19","doi-asserted-by":"publisher","first-page":"643","DOI":"10.4155\/tde.11.19","volume":"2","author":"JA Y\u00e1\u00f1ez","year":"2011","unstructured":"Y\u00e1\u00f1ez JA, Remsberg CM, Sayre CL, Forrest ML, Davies NM. Flip-flop pharmacokinetics \u2013 delivering a reversal of disposition: challenges and opportunities during drug development. Ther Deliv. 2011;2:643\u201372. https:\/\/doi.org\/10.4155\/tde.11.19.","journal-title":"Ther Deliv"},{"key":"1543_CR20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/psp4.12909","volume":"12","author":"IHS Kuan","year":"2023","unstructured":"Kuan IHS, Wright DFB, Duffull SB. The influence of flip-flop in population pharmacokinetic analyses. CPT PSP. 2023;12:285\u20137. https:\/\/doi.org\/10.1002\/psp4.12909.","journal-title":"CPT PSP"},{"key":"1543_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00228-010-0927-x","volume":"67","author":"M Cusato","year":"2011","unstructured":"Cusato M, Allegri M, Niebel T, Ingelmo P, Broglia M, Braschi A, Regazzi M. Flip-flop kinetics of ropivacaine during continuous epidural infusion influences its accumulation rate. Eur J Clin Pharmacol. 2011;67:399\u2013406. https:\/\/doi.org\/10.1007\/s00228-010-0927-x.","journal-title":"Eur J Clin Pharmacol"},{"key":"1543_CR22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.bjane.2021.10.010","volume":"73","author":"NM Fonseca","year":"2023","unstructured":"Fonseca NM, Guimar\u00e3es GMN, Pontes JPJ, Azi LMTDA, de \u00c1vila Oliveira R. Safety and effectiveness of adding fentanyl or sufentanil to spinal anesthesia: systematic review and meta-analysis of randomized controlled trials. Braz J Anesthesiol (Engl Ed). 2023;73:198\u2013216. https:\/\/doi.org\/10.1016\/j.bjane.2021.10.010.","journal-title":"Braz J Anesthesiol (Engl Ed)"},{"key":"1543_CR23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/14740338.2019.1617271","volume":"18","author":"ML van Zuylen","year":"2019","unstructured":"van Zuylen ML, Ten Hoope W, Bos E, Hermanides J, Stevens MF, Hollmann MW. Safety of epidural drugs: a narrative review. Expert Opin Drug Saf. 2019;18:591\u2013601. https:\/\/doi.org\/10.1080\/14740338.2019.1617271.","journal-title":"Expert Opin Drug Saf"},{"key":"1543_CR24","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0885-3924(92)90061-L","volume":"7","author":"JA Grass","year":"1992","unstructured":"Grass JA. Sufentanil: Clinical use as postoperative analgesic\u2014epidural\/intrathecal route. J Pain Symptom Manag. 1992;7:271\u201386. https:\/\/doi.org\/10.1016\/0885-3924(92)90061-L.","journal-title":"J Pain Symptom Manag"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-025-01543-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40262-025-01543-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-025-01543-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T12:58:32Z","timestamp":1758977912000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40262-025-01543-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,29]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1543"],"URL":"https:\/\/doi.org\/10.1007\/s40262-025-01543-y","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,29]]},"assertion":[{"value":"9 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2025","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to correct the affiliation for the author Ma\u0142gorzata Waszczuk.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Support was provided solely from institutional and\/or departmental sources","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The R code, data, and Stan code used to analyze the data are publicly available in the GitHub repository ().","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data and Code Availability"}},{"value":"The study was performed in accordance with the approval of the Institutional Bioethics Committee (no. 1144\/18) and was registered on ClinicalTrials.gov (NCT06069219). Written informed consent was obtained from all patients prior to enrolment.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval\/Consent to Participate\/Consent for Publication"}},{"value":"P.W., A.B., and A.B-d.M. contributed to writing; A.B. and A.B-d.M. to conceptualization and methodology; D.S. and M.W. to analytical method development and assays; J.B. to data curation; P.W. and P.O. to statistical methodology, data analysis, and visualization; and K.K., T.B., J.S., A.K., and T.K. to clinical care of patients and data collection.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}